Phosphorylation by Protein Kinase C Is Required For Acute Activation of Cystic Fibrosis Transmembrane Conductance Regulator by Protein Kinase A*

(Received for publication, November 7, 1996, and in revised form, December 15, 1996)

Yanlin Jia Dagger , Ceri J. Mathews § and John W. Hanrahan

From the Department of Physiology, McGill University, 3655 Drummond Street, Montréal, Québec H3G 1Y6, Canada

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Protein kinase A (PKA) stimulates Cl secretion by activating the cystic fibrosis transmembrane conductance regulator (CFTR), a tightly regulated Cl- channel in the apical membrane of many secretory epithelia. The CFTR channel is also modulated by protein kinase C (PKC), but the regulatory mechanisms are poorly understood. Here we present evidence that PKA-mediated phosphorylation alone is not a sufficient stimulus to open the CFTR chloride channel in the presence of MgATP; constitutive PKC phosphorylation is essential for acute activation of CFTR by PKA. When patches were excised from transfected Chinese hamster ovary cells, CFTR responses to PKA became progressively smaller with time and eventually disappeared. This decline in PKA responsiveness did not occur in the presence of exogenous PKC and was reversed by the addition of PKC to channels that had become refractory to PKA. PKC enhanced PKA stimulation of open probability without increasing the number of functional channels. Short-term pretreatment of cells with the PKC inhibitor chelerythrine (1 µM) reduced the channel activity that could be elicited by forskolin in cell-attached patches. Moreover, in whole cell patches, acute stimulation of CFTR currents by chlorophenylthio-cAMP was abolished by two chemically unrelated PKC inhibitors, although an abrupt, partial activation was observed after a delay of >15 min. Modulation by PKC was most pronounced when basal PKC phosphorylation was reduced by briefly preincubating cells with chelerythrine. Constitutive PKC phosphorylation in unstimulated cells permits the maximum elevation of open probability by PKA to reach a level that is ~60% of that attained during in vitro exposure to both kinases. Differences in basal PKC activity may contribute to the variable cAMP responsiveness of CFTR channels in different cell types.


INTRODUCTION

The regulatory domain of cystic fibrosis transmembrane conductance regulator (CFTR)1 has nine dibasic consensus sequences for phosphorylation by protein kinase A (PKA) and at least seven potential sites for phosphorylation by protein kinase C (PKC). There is direct evidence for phosphorylation of serines 660, 700, 712, 737, 753, 768, 795, and 813 by PKA (1-3) and serines 660, 686, 700, and 790 by PKC (2). In freshly excised membrane patches, CFTR Cl- channels are activated by exposure to the PKA catalytic subunit and MgATP (4, 5). Altering the four major sites of in vivo phosphorylation reduces forskolin-stimulated Cl- permeability (1, 6), whereas removal of all 10 dibasic sites and the additional monobasic site Ser753 further reduces, but does not eliminate, PKA stimulation of CFTR in both intact cells and excised patches (6, 7). There is little doubt that PKA-mediated phosphorylation is the primary mechanism controlling CFTR Cl- channel activity, consistent with early evidence that cAMP stimulates transepithelial secretion, in part by increasing apical membrane Cl- conductance (8-12).

The role of PKC in regulating the CFTR channel is less certain. Exogenous PKC causes a small stimulation of channel activity when added during the first few minutes after patches are excised (4, 13). PKC enhances both the rate and magnitude of subsequent PKA stimulation of open probability (po) by approximately 2-fold and 50%, respectively (4). Potentiation of cAMP responses has also been observed in phorbol-stimulated Xenopus oocytes expressing CFTR (14), HT-29 cells (15), and pancreatic duct cells, in which the PKC agonist beta -phorbol 12,13-dibutyrate increased cAMP-induced whole cell CFTR Cl- current by 31% although having no effect on basal currents (16). Potentiation has received several different interpretations. The effects of PKC on excised patches (4) and phorbols on T84 and C127 were suggested to involve PKC regulation of the CFTR channel itself (17, 18). However, to explain the apparent increase in Cl- current by PKC in pancreatic duct cells (expressed as pA/pF), it was proposed that PKC reduces cell membrane area rather than increasing channel activity (16). By contrast, exocytotic addition of new channels to the plasma membrane was suggested to explain the potentiation in HT-29 cells (15).

Studying CFTR function after phorbol treatment is problematic when both its expression (19) and degradation (20) are strongly influenced by PKC activity. Another problem has been the difficulty of distinguishing acute PKC-induced changes in po from changes in the number of functional channels (N). Finally, the responsiveness of CFTR to PKA stimulation varies widely among different cell types even when channels are studied in excised patches. The reasons for this variation are not known.

Here we present evidence that PKC-mediated phosphorylation not only potentiates CFTR responses but is, in fact, essential for acute PKA activation of CFTR channels. This requirement for PKC only became apparent when the PKA response was studied after prolonged rundown in excised patches or after short-term pretreatment with PKC inhibitors, presumably because constitutive PKC phosphorylation was slowly removed by phosphatase activity under these conditions (4, 21, 22).


EXPERIMENTAL PROCEDURES

Cell Culture

Chinese hamster ovary (CHO) cells and baby hamster kidney (BHK) cells that had been stably transfected with plasmids directing the expression of wild-type CFTR were provided by Drs. X.-B. Chang and J. R. Riordan (Mayo Clinic, Scottsdale, AZ; Ref. 6) and F. Siebert (University of Toronto, Toronto, Ontario, Canada; Ref. 7). CHO and BHK cells were cultured as described previously (4, 42), subcultured on glass coverslips in 35-mm Petri dishes, and used in patch clamp experiments 2-5 days after plating.

Single Channel Studies

Single channels were recorded using the cell-attached and inside-out patch clamp configurations (23; also see Ref. 4). The bath and pipette solutions contained 150 mM NaCl, 10 mM TES, and 2 mM MgCl2 (pH 7.2). Fresh MgATP (1 mM final concentration) and forskolin (5 µM) were added to the bath before each experiment. Experiments were carried out at room temperature (~22 °C). Single channel currents were amplified (Axopatch 200; Axon Instruments Inc., Foster City, CA), recorded on video tape (PCM 418; Medical Systems Corp, Greenvale, NY), and analyzed as described previously (4). The pipette voltage was held at -30 mV during cell-attached recordings and then switched to +30 mV after excision so that the potential across the membrane patch would be similar in both configurations (approximately -30 mV). Channel activity was allowed to run down for 10 min after excision to allow dephosphorylation by membrane-associated phosphatase activity prior to the addition of protein kinases. To estimate the N in the patch, AMP-PNP (1 mM) was added to the bath at the end of each experiment to lock CFTR channels in the open state so they could be counted (24). po was calculated as the mean number of channels open during segments of the record (Npo) divided by the value of N determined using AMP-PNP. The catalytic subunit of PKA was obtained from Promega (Madison, WI). Rat brain PKC II, predominantly Ca2+- and phospholipid-dependent PKC isoforms, was prepared in the laboratory of M. P. Walsh (University of Calgary, Alberta, Canada; see Ref. 4). MgATP and the lipid activator 1,2-dioctanoylglycerol (8:0) (DiC8) were purchased from Sigma. ATP was added from a 100 mM stock solution in buffer. DiC8 was dissolved in chloroform at 5 mM and stored under nitrogen at -20 °C before use. Chelerythrine chloride (Biomol, Plymouth Meeting, PA) was prepared as a 10 mM stock in ME2SO, stored at -20 °C, and diluted in bath solution immediately before use (1 µM final concentration).

Whole Cell Studies

In whole cell experiments, the bath (extracellular) solution contained 150 mM NaCl, 10 mM TES, and 2 mM MgCl2 (pH 7.40) and was supplemented with 50 mM sucrose to minimize swelling-activated Cl currents. The pipette (intracellular) solution contained 110 mM N-methyl-D-glucamine-aspartate, 30 mM N-methyl-D-glucamine-Cl, 1 mM MgCl2, 10 mM TES, and 0.1 mM 1,2-bis-(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrasodium salt; (Biomol) (pH 7.20). MgATP (1 mM) was added to the pipette solution from a 100 mM stock in TES buffer. Stock cpt-cAMP and 8-bromo-cAMP solutions (50 mM) were prepared in distilled water using their sodium salts and used at a final concentration of 100 µM. The PKC inhibitor Gö6976 (Calbiochem) was prepared in ME2SO and diluted in bath solution immediately before use (final concentration, 500 nM). It was also included in the pipette solution, and experiments were begun 4 min after obtaining the whole cell configuration to allow its diffusion into the cell (25). When chelerythrine was used, it was prepared as described above and added at a final concentration of 1 µM for 30 min prior to recording whole cell currents.

Whole cell currents were recorded using pipettes pulled from thick-walled borosilicate glass (1.5-3 MOmega ). After obtaining seals, pipette capacitance was canceled using the internal circuitry of the patch clamp (Axopatch 1C; Axon). The whole cell recording configuration was obtained by applying excess suction, and cell capacitance was measured and then canceled. In most experiments, Vm was held at 0 mV for 1 s between alternating pulses to ± 60 mV (1-s duration). Current-voltage relationships were generated by stepping from -100 to +100 mV in 10-mV increments, returning to the holding potential of 0 mV between pulses. Currents are expressed per unit cell capacitance (pA/pF) to allow comparison of data from different cells. Outward (positive) current corresponds to Cl- ions entering the cell. The Nernst prediction for a perfectly Cl--selective membrane was -39 mV under the conditions used. The leak current at +60 mV (+63.4 ± 14.7 pA/pF) was small compared with the mean cAMP-stimulated CFTR current (8.6 ± 1.4%), and therefore was not subtracted. Mean pipette capacitance was 7.87 ± 0.08 pF (n = 46), mean whole cell capacitance was 13.1 ± 0.6 pF (n = 51), and the average access resistance of the pipettes was 15.6 ± 1.0 MOmega (n = 47).

Data Analysis

The number of opening transitions during each segment of >3 min was counted and used to estimate the mean burst (tau open) and interburst (tau closed) durations according to: tau open = (N × po) (time)/(number of openings) and tau closed = (N - N × po) (time)/(number of openings - 1), where N is the number of channels estimated by locking channels open with AMP-PNP, and po is the single-channel open probability (31).2 Data are expressed as means ± S.E. Paired t tests and Mann-Whitney U tests were performed using GraphPad InStat software (Biosoft, Cambridge, United Kingdom).


RESULTS

Effect of PKC on CFTR Responsiveness to PKA in Excised Membrane Patches

Exposing transfected CHO cells to forskolin activated CFTR Cl- channels in 15 of 15 cell-attached patches (Fig. 1). The po under cell-attached conditions was 0.32 ± 0.038 (n = 4). As in previous studies, po declined spontaneously when patches were excised into a bath solution containing 1 mM MgATP. When exogenous PKA (200 units/ml) was added to the bath, the magnitude of the CFTR channel response depended on the time that had elapsed since excision. Robust PKA stimulation was observed ~2 min after patches were excised, whereas PKA usually failed to activate CFTR Cl- channels when patches were excised and continuously exposed to 1 mM MgATP for 10 min. When patches were excised for 10 min and allowed to become refractory to PKA, responsiveness could be fully restored by adding PKC and the lipid cofactor DiC8 to the cytoplasmic side in the continued presence of PKA (Fig. 1B). This stimulation after the addition of PKC and DiC8 was elicited by the PKA already present in the bath rather than by PKC itself, because addition of PKC and DiC8 after the same delay had no effect in the absence of PKA (Fig. 1C). Moreover, CFTR responsiveness to PKA did not decline if PKC was present during the 10-min period following excision (Fig. 1D). Taken together, these results suggest that PKA phosphorylation alone is not a sufficient stimulus to open the CFTR channel; constitutive phosphorylation by PKC is also required.


Fig. 1. Responsiveness of CFTR channels to PKA catalytic subunit under various conditions. Forskolin (5 µM) and MgATP (1 mM) were present continuously in the bath. Recordings started in the cell-attached configuration with a pipette voltage of -30 mV. Data were filtered at 50 Hz (eight-pole Bessel filter). The interruption in each trace indicates the time during which it was excised and pipette voltage was changed to +30 mV. Downward deflections represent inward currents carried by Cl- ions flowing into the pipette. PKA (200 units/ml), PKC (3.78 nM) and DiC8 (5 µM) were added to the cytoplasmic side at the arrow. A, stimulation of CFTR activity elicited by the addition of PKA within 2 min of rundown. B, inability of PKA to stimulate CFTR channels when added 10 min after excision and subsequent stimulation after addition of PKC and DiC8. C, trace showing that PKC and DiC8 had no effect on channel activity in the absence of PKA when added after the same time interval as in B. Note that at least two channels were active in this patch in the cell-attached configuration. D, presence of PKC and DiC8 during the 10-min period after excision prevents the loss of responsiveness to PKA (compare with trace B).
[View Larger Version of this Image (18K GIF file)]


Fig. 2 summarizes the dependence of the PKA response on time after excision and the effect of exogenous PKC on channel responsiveness to PKA. All channels were locked open at the end of each experiment using AMP-PNP to determine N. This number was then used to calculate po, as described under "Experimental Procedures." CFTR channels were consistently reactivated if PKA was added within 2 min after excision; however, this stimulation of po was progressively reduced with time after excision (Fig. 2A). The mean po values during the PKA responses are shown in Fig. 2B. The interval between excision and PKA addition was inversely related to the po during PKA stimulation, which eventually declined to 0. By contrast, responsiveness to PKA did not decline when patches were exposed to PKC, DiC8, and MgATP throughout the 10-min period after excision. Single-channel po in the presence of PKA and PKC was 0.46 ± 0.07 (n = 3), similar to that observed for the same patches during forskolin stimulation prior to excision (po = 0.42 ± 0.02; p > 0.05; Fig. 2C). This po is higher than that calculated for patches excised from unstimulated cells into the bath solution containing PKA and ATP (0.22 ± 0.04; Ref. 24), when the number of channels in each patch was corrected using AMP-PNP. Thus, in addition to having a permissive effect on po (Fig. 1B), PKC also potentiated the PKA response under these conditions by increasing the maximum po elicited by PKA approximately 2-fold, as reported previously (4).


Fig. 2. Effects of PKA on po. A, time dependence of PKA activation of CFTR channels in three excised patches. Experiments were carried out in bath solution containing forskolin (5 µM) and MgATP (1 mM). The number of channels was determined at the end of each experiment by locking them open using AMP-PNP. Patches were excised at time 0 and exposed to PKA after 1 (bullet ), 5 (open circle ), or 10 (down-triangle) minutes, as indicated by the arrows. Note the loss of PKA responsiveness with time after excision. B, po determined after PKA addition at various times following excision as shown in A. C, po of CFTR channels and their response to PKA when added 10 min after excision in the absence (bullet ) or presence (open circle ) of PKC (3.78 nM) and DiC8 (5 µM). Values are mean ± S.E. (bars); n = 3-4 patches. Conditions were the same as in Fig. 1.
[View Larger Version of this Image (18K GIF file)]


Mechanism of PKC Dependence

To further investigate whether PKC regulates the number of channels opened by PKA or the po of individual channels, patches containing a small number of CFTR channels were excised from CHO cells and exposed to PKA after a delay of 5 min. Adding PKC and DiC8 to the same patches 5 min after PKA addition did not increase the maximum number of channels open simultaneously, which was identical to the value of N determined using AMP-PNP at the end of the experiment (Fig. 3A). By contrast, po of single channels calculated from the mean number of channels open and N was approximately doubled (p < 0.005; Fig. 3B). When BHK cells, which express more than a 10-fold higher density of CFTR channels, were pretreated with the PKC inhibitor chelerythrine (1 µM) for 5 min, adding PKA to the excised patches caused only a small increase in channel activity, although the number of channels locked open by AMP-PNP was high, indicating the channels were active when exposed to PKA alone but simply had low po. For example, the patch shown in Fig. 3D contained at least 40 active channels, each with po < 0.05. Addition of PKC did not increase the number of channels locked open by AMP-PNP (Fig. 3D), further evidence that channels were already functional after PKA alone. Thus, PKC acts by enhancing PKA stimulation of po rather than by increasing N. PKC shortened the mean closed time (p < 0.01) but had no effect on mean burst duration (open time; p > 0.05) during PKA stimulation (Fig. 3C). The lower po in Fig. 3D (<0.05) compared with Fig. 3B (~0.2) is explained by pretreatment of the former with chelerythrine to reduce constitutive PKC phosphorylation. These results suggest there is some constitutive PKC activity in unstimulated cells, which permits submaximal responses to PKA stimulation. This possibility is examined below using cell-attached and whole cell patches.


Fig. 3. Mechanism of the PKC dependent response to PKA: an effect on N or po? Effect of PKC on the number of functional channels in the patch (A) and po (B). PKA was added to the bath 5 min after excision, and PKC and DiC8 were added 10 min later. AMP-PNP (1 mM) was added at the end of each experiment to lock functional channels in the open burst state. n = 6 patches; *, p < 0.01; **, p < 0.005. C, mean duration of open bursts (To) and interbursts (Tc) during exposure of the patches to PKA or to both PKA and PKC. Note that only the interburst duration is affected by PKC potentiation. D, inhibiting constitutive PKC phosphorylation reduces the po response to PKA without reducing the N. This recording, which is from a patch containing >40 channels, begins immediately after the patch was excised from a cell that had been pretreated with chelerythrine for 5 min. Addition of PKA stimulated CFTR channel activity (see expanded trace) but caused only a slight increase in macroscopic current. Nevertheless, subsequent addition of AMP-PNP gradually increased the current by at least 20-fold, consistent with the locking open of a large number of channels that initially had low open probability (po <0.05) during stimulation by PKA alone. Adding PKC and DiC8 did not cause additional channels to lock. Conditions were the same as in Fig. 1.
[View Larger Version of this Image (22K GIF file)]


Effect of Inhibiting Constitutive PKC Activity in Intact Cells and Whole Cell Patches

To investigate whether endogenous PKC activity is required for cAMP activation of CFTR in intact cells, we tested the effect of preincubating cells with chelerythrine, a specific PKC inhibitor (26, 27). Pretreatment with chelerythrine abolished forskolin activation of CFTR channels in 13 of 16 cell-attached patches (Fig. 4). In parallel control experiments forskolin activated CFTR Cl- channels in 15 of 15 cell-attached patches. Similarly, under control conditions, cpt-cAMP (100 µM) activated whole cell CFTR chloride currents in 6 of 6 cells with a time to half-maximal activation of 2.1 ± 0.6 min under control conditions but in other experiments had no effect within 12 min when cells were pretreated with chelerythrine (Fig. 5). Moreover, in further studies, a selective inhibitor of the Ca2+-dependent alpha  and beta 1 isoforms of PKC (Gö6976; Refs. 28-30) also prevented acute activation of CFTR whole cell Cl- currents by cpt-cAMP (Fig. 5), although partial activation of CFTR was observed after prolonged treatment with cpt-cAMP in the presence of either chelerythrine or Gö6976. The time to half-maximal activation of this delayed response was 23.9 ± 6.2 min in chelerythrine-treated cells and 21.5 ± 5.1 min in Gö6976-treated cells, a lag that was approximately 10-fold longer than for control cells, which had been treated with cpt-cAMP in the absence of PKC inhibitors (p = 0.0022 and 0.0022, respectively; Mann-Whitney U test; Fig. 5, D and E). The delayed response was abrupt, suggesting it may be caused by sudden activation of an alternative pathway that circumvents inhibition of PKC activity. Similar results were obtained when chelerythrine-treated cells were exposed to 8-bromo-cAMP rather than cpt-cAMP (data not shown). By contrast, a delayed response did not develop during very long recordings in the absence of cAMP analogs (range, 31-50 min; n = 3). These results suggest that the inhibition of PKC can eventually be overcome by activation of an alternative pathway, which restores the responsiveness of CFTR channels to PKA.


Fig. 4. Effect of chelerythrine pretreatment on forskolin-activated CFTR channels in cell-attached patches. Cells were exposed to chelerythrine chloride (1 µM) for 30 min before obtaining cell-attached patches. The Npo of CFTR channels was compared during stimulation of control or chelerythrine-treated cells by 5 µM forskolin. *, p < 0.001 compared with control conditions (sign rank test).
[View Larger Version of this Image (10K GIF file)]



Fig. 5. Effect of inhibiting endogenous PKC activity on the response of CFTR channels to cpt-cAMP in BHK cells. A, whole cell currents recorded under control conditions, during stimulation by cpt-cAMP (100 µM), and following superfusion of the cell with cpt-cAMP-free solution for 32 min. Data were low pass-filtered at 100-500 Hz using a three-pole Bessel filter and sampled at 200-1000 Hz. B, steady state current-voltage relationships for the whole cell currents shown in A. C, effect of cpt-cAMP on whole cell currents recorded at +60 mV under control conditions (open circle ) or in the presence of the PKC inhibitors Gö6976 (triangle ) or chelerythrine chloride (down-triangle). bullet , mean ± S.E. (bars) of six control cells. D, delay between addition of cpt-cAMP and half-maximal stimulation of the whole cell current (T0.5) under control conditions (open bar, n = 6) and in the presence of chelerythrine (CHEL) or Gö6976 (hatched bars, n = 6 for each inhibitor). E, rate of CFTR current activation (measured between 10 and 90% of maximal response) under control conditions (open bar) and in the presence of chelerythrine (CHEL) or Gö6976 (hatched bars, n = 6 for each inhibitor). *, significant difference from control (p < 0.0022 using the Mann-Whitney U test).
[View Larger Version of this Image (27K GIF file)]



DISCUSSION

The CFTR chloride channel is regulated by PKA- and PKC-mediated phosphorylation; however, the relationship between these kinases has not been studied in detail. Previous work suggested that PKC increases the stimulation of po by PKA approximately 2-fold (4); however, no precautions were taken in those early experiments to minimize PKC phosphorylation prior to testing kinase effects. A major finding of the present study is that PKC regulation of CFTR is mainly constitutive, at least in the two mammalian expression systems studied. Using somewhat different protocols we found that PKC not only potentiates responses but is required for acute stimulation of CFTR by PKA. This dependence on PKC was observed in excised and whole cell patches and in intact cells, but only when protocols were designed to allow dephosphorylation of PKC sites, which may explain why a strict dependence on PKC has not been observed previously. Although PKC is permissive and modulates the PKA responses over a wide range in excised patches (po = 0-0.7), basal PKC activity in resting CHO cells appears sufficient to maintain PKA responsiveness near its maximal level.

The present results confirm that forskolin stimulates CFTR channels in CHO and BHK cells, and that CFTR channel activity declines rapidly when patches are excised in the absence of PKA, consistent with dephosphorylation of PKA sites by membrane-associated phosphatases (4). Moreover, PKA reactivates CFTR chloride channels when added soon after patches are excised but not when more than 10 min have elapsed. We attribute this decline in responsiveness to PKA to slow dephosphorylation of PKC sites, because it did not occur in the presence of PKC and was reversed by the addition of PKC to the bath. Although PKC alone caused an apparent, partial (10%) activation in this and previous studies, the small PKC response may be a manifestation of the permissive effect of PKC. The early experiments suggesting activation by PKC alone were not preceded by a lengthy rundown period such as the one shown in Fig. 1C. Thus the stimulation by PKC may have been due to the reactivation of channels that had become dephosphorylated at a permissive PKC site but retained some residual PKA phosphorylation. Consistent with this explanation, some CFTR activity was observed in the present work when patches were excised directly into PKC-containing buffer lacking PKA, comparable with that reported previously when PKC was added immediately after channel rundown (po = 0.04, (4) and 0.034 ± 0.0125, (31)). Regulation of Cl- secretion in native epithelia is complicated because PKC has multiple sites of action, including inhibition of basolateral potassium conductance. Nevertheless, there are several reports of phorbol ester stimulation of Cl- secretion in airway and other epithelia (32-36) that might be explained by basal PKA activity combined with the permissive effect of PKC described here.

PKA reactivated CFTR channels when added 2 min after excision but not when added 10 min after excision; therefore, the permissive PKC site(s) may be dephosphorylated more slowly than the PKA sites mediating initial rundown of channel activity. The rundown caused by dephosphorylation of PKA sites occurs within 100 s when patches are excised from these cells at room temperature (22). Biochemical studies will be needed to assess whether constitutive PKC phosphorylation is required for phosphorylation of CFTR by PKA as in hierarchical phosphorylation (37) or whether PKA phosphorylation of CFTR is normal in the absence of PKC and only the functional response of the channel to PKA phosphorylation is attenuated. Prestimulating CHO cells with phorbol ester did not noticeably increase phosphorylation of CFTR protein during forskolin stimulation (6); however, the functional responses may depend on trace phosphorylation at cryptic sites, which could escape detection. Interdependent PKC and PKA regulation may allow more precise control of CFTR activity, as would regulation by multiple phosphatases acting at PKA or PKC sites.

Permissive control of cAMP stimulation by PKC was also observed in intact cells; PKC inhibitors greatly reduced forskolin-stimulated CFTR activity in cell-attached patches and abolished acute stimulation of whole cell CFTR currents by cpt-cAMP. Thus constitutive, endogenous PKC activity is sufficient for activation of CFTR by forskolin or cAMP. The fact that exogenous PKC needs to be added to excised patches implies that the endogenous PKC activity responsible for priming CFTR is not membrane-associated, although it remains a formal possibility that PKC activity in the patches is membrane-associated but requires an additional cytoplasmic factor for activity. A membrane-associated PKC isoform has been shown previously to stimulate CFTR channels when added to patches excised from NIH-3T3 cells (13).

CFTR channels were weakly responsive to PKA when cells were briefly pretreated with chelerythrine (5 instead of >30 min) or when patches were excised from cells and allowed to run down for only 5 min so that some PKC phosphorylation would remain. To assess whether the permissive effect of PKC involved an increase in po or the number of functional channels under these conditions, we took the advantage of the previous findings that the poorly hydrolyzable analog AMP-PNP causes CFTR to become locked in an open burst state in which po approx  1.0 (38, 39). Exposure to PKC increased the po without altering the number of functional (i.e. PKA-responsive and locked by AMP-PNP) channels in the patches. This result was most obvious when CHO patches containing only a few channels were used, since the probability that all the functional channels would be open simultaneously was highest under these conditions.

To ensure that increases in N were not missed by studying cells with low CFTR channel density, we also examined BHK cells that contained between 40 and several hundred CFTR channels per patch. When BHK cells were pretreated with chelerythrine for 5 min, subsequent exposure of excised patches to PKA caused only a small stimulation, although the number of functional channels as defined by their susceptibility to locking by AMP-PNP was high and was not increased further by PKC. If exocytotic insertion of CFTR channels is stimulated by PKC, it was not apparent in the patches we studied and did not contribute to the potentiation reported in this article. Kinetic analysis of patches from CHO cells revealed that PKC decreased the mean closed time during PKA stimulation and had no effect on the mean open time. These results are consistent with an increased rate of channel opening, such as the one that accompanies phosphorylation-induced increases in ATP affinity (24, 31). In a CFTR mutant with alterations at all 10 dibasic consensus PKA sequences (10SA; Ref. 6), the reduction in po was associated with a lower bursting rate (i.e. a longer closed time) rather than a shortening of the bursts (24). Strong potentiation by PKC was still observed in the 10SA mutant, which lacks serines at positions 660, 686, and 700; therefore, these dual PKA and PKC sites are not essential for PKC-dependent regulation of PKA responsiveness.

PKC isozymes have been classified into several distinct groups (40). The "Ca-dependent" group (alpha , beta I, beta II, and gamma  isozymes) contains a putative Ca2+ binding site, which is lacking in the "Ca-independent" group (delta , epsilon , eta , theta , and µ isozymes). Another "atypical" group (including the zeta  and lambda  isozymes) is structurally distinct and poorly characterized. Based on its sensitivity to Gö6976, the permissive regulation in CHO and BHK cells appears to be mediated by endogenous Ca-dependent alpha  or beta I forms. Nevertheless, PKA responsiveness in excised patches was restored by the addition of rat brain PKC, which consists mainly of the Ca-dependent beta II isozyme, and the role of PKC isozymes in CFTR regulation may vary according to cell type.

Although the initial experiments in this study suggested that PKA responsiveness is completely dependent on PKC phosphorylation, we were surprised to find that whole Cl- cell currents suddenly became responsive to cpt-cAMP in the presence of PKC inhibitors after a delay of more than 20 min. Since channels in excised patches did not regain responsiveness to PKA during long exposures (>30 min) in the absence of PKC, the surrogate pathway that overcomes PKC inhibition in whole cell patches is probably not membrane-delimited. In whole cell studies, similar responses were observed with two structurally unrelated PKC inhibitors, further evidence that inhibition of acute cAMP stimulation is a bona fide effect on PKC. Also, PKA responsiveness did not increase gradually in whole cell patches in a manner consistent with the loss of inhibitor potency. Rather, the delayed response developed abruptly after 20 min, as if the dependence on PKC was relieved by activation of an alternate signaling pathway.

In summary, these results indicate that PKA-mediated phosphorylation alone is not a sufficient stimulus to activate the CFTR chloride channel. We propose that under normal conditions, constitutive phosphorylation of CFTR by PKC has a permissive role in priming the channel for acute activation by PKA. Thus maneuvers that lower this constitutive phosphorylation reveal PKC effects that are much more profound than previously suspected. These results have implications for functional studies of CFTR phosphoforms; PKA-stimulated channel activity in membrane patches and bilayers will be dictated by residual PKC phosphorylation. Variations in constitutive phosphorylation by PKC may also help explain the variable responsiveness of CFTR channels to stimulation by PKA in different expression systems (7, 41).


FOOTNOTES

*   This study was supported in part by the Canadian Cystic Fibrosis Foundation, the Medical Research Council, and the NIDDK, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by the Respiratory Health Network of Centers of Excellence and a fellow of the Canadian Lung Association/Medical Research Council and the Canadian Cystic Fibrosis Foundation.
§   Supported by a fellowship from the Montréal Chest Institute.
   A Medical Research Council scientist. To whom correspondence should be addressed. Tel.: 514-398-8320; Fax: 514-398-7452; E-mail: hanrahan{at}physio.mcgill.ca.
1    The abbreviations used are: CFTR, cystic fibrosis transmembrane conductance regulator; PKA, protein kinase A; PKC, protein kinase C; po, open probability; N, number of functional channels; CHO, Chinese hamster ovary; BHK, baby hamster kidney; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; AMP-PNP, 5'-adenylyl beta ,gamma -imidodiphosphate; DiC8, 1,2-dioctanoylglycerol (8:0); pF, picofarad; cpt-cAMP, chlorophenylthio-cAMP.
2    C. J. Mathews, J. A. Tabcharani, and J. W. Hanrahan, manuscript in preparation.

Acknowledgment

We thank Jie Liao for culturing the cells.


REFERENCES

  1. Cheng, S. H., Rich, D. P., Marshall, J., Gregory, R. J., Welsh, M. J., and Smith, A. E. (1991) Cell 66, 1027-1036 [Medline] [Order article via Infotrieve]
  2. Picciotto, M. R., Cohn, J. A., Bertuzzi, G., Greengard, P., and Nairn, A. C. (1992) J. Biol. Chem. 267, 12742-12752 [Abstract/Free Full Text]
  3. Cohn, J. A., Nairn, A. C., Marino, C. R., Melhus, O., and Kole, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 2340-2344 [Abstract]
  4. Tabcharani, J. A., Chang, X., Riordan, J. R., and Hanrahan, J. W. (1991) Nature 352, 628-631 [CrossRef][Medline] [Order article via Infotrieve]
  5. Berger, H. A., Anderson, M. P., Gregory, R. J., Thompson, S., Howard, P. W., Maurer, R. A., Mulligan, R., Smith, A. E., and Welsh, M. J. (1991) J. Clin. Invest. 88, 1422-1431 [Medline] [Order article via Infotrieve]
  6. Chang, X.-B., Tabcharani, J. A., Hou, Y.-X., Jensen, T. J., Kartner, N., Alon, N., Hanrahan, J. W., and Riordan, J. R. (1993) J. Biol. Chem. 268, 11304-11311 [Abstract/Free Full Text]
  7. Seibert, F. S., Tabcharani, J. A., Chang, X.-B., Dulhanty, A. M., Mathews, C., Hanrahan, J. W., and Riordan, J. R. (1995) J. Biol. Chem. 270, 2158-2162 [Abstract/Free Full Text]
  8. Klyce, S. D., and Wong, R. K. S. (1977) J. Physiol. (Lond.) 266, 777-799 [Abstract]
  9. Shorofsky, S. R., Field, M., and Fozzard, H. A. (1983) J. Membr. Biol. 72, 105-115 [Medline] [Order article via Infotrieve]
  10. Nagel, W., and Reinach, P. (1980) J. Membr. Biol. 56, 73-79 [Medline] [Order article via Infotrieve]
  11. Frizzell, R. A., Field, M., and Schultz, S. G. (1979) Am. J. Physiol. 236, F1-F8 [Medline] [Order article via Infotrieve]
  12. Welsh, M. J., Smith, P. L., and Frizzell, R. A. (1983) J. Membr. Biol. 71, 209-218 [Medline] [Order article via Infotrieve]
  13. Berger, H. A., Travis, S. M., and Welsh, M. J. (1993) J. Biol. Chem. 268, 2037-2047 [Abstract/Free Full Text]
  14. Sullivan, S. K., Swamy, K., and Field, M. (1991) Am. J. Physiol. 260, C664-C669 [Abstract/Free Full Text]
  15. Bajnath, R. B., Groot, J. A., Dejonge, H. R., Kansen, M., and Bijman, J. (1993) Pflueg. Arch. Eur. J. Physiol. 425, 100-108
  16. Winpenny, J. P., McAlroy, H. L., Gray, M. A., and Argent, B. E. (1995) Am. J. Physiol. 268, C823-C828 [Abstract/Free Full Text]
  17. Dechecchi, M. C., Rolfini, R., Tamanini, A., Gamberi, C., Berton, G., and Cabrini, G. (1992) FEBS Lett. 311, 25-28 [CrossRef][Medline] [Order article via Infotrieve]
  18. Dechecchi, M. C., Tamanini, A., Berton, G., and Cabrini, G. (1993) J. Biol. Chem. 268, 11321-11325 [Abstract/Free Full Text]
  19. Trapnell, B. C., Chu, C., Paakko, P. K., Banks, T. C., Yoshimura, K., Ferrans, V. J., Chernick, M. S., and Crystal, R. G. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6565-6569 [Abstract]
  20. Breuer, W., Glickstein, H., Kartner, N., Riordan, J. R., Ausiello, D. A., and Cabantchik, I. Z. (1993) J. Biol. Chem. 268, 13935-13939 [Abstract/Free Full Text]
  21. Haws, C. M., Finkbeiner, W. E., Widdicombe, J. H., and Wine, J. J. (1993) Pediatr. Pulmonol. 18, Suppl. 9, 215-216
  22. Becq, F., Jensen, T. J., Chang, X.-B., Savoia, A., Rommens, J. M., Tsui, L.-C., Buchwald, M., Riordan, J. R., and Hanrahan, J. W. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 9160-9164 [Abstract/Free Full Text]
  23. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981) Pflueg. Arch. Eur. J. Physiol. 391, 85-100
  24. Mathews, C. J., Tabcharani, J. A., Chang, X.-B., Riordan, J. R., and Hanrahan, J. W. (1996) Pediatr. Pulmonol. 21, Suppl. 13, 221 (abstr.)
  25. Marty, A., and Neher, E. (1995) in Single Channel Recording (Sakmann, B., and Neher, E., eds), pp. 31-52, Plenum Press, New York
  26. Jarvis, W. D., Turner, A. J., Provirk, L. F., Traylor, R. S., and Grant, S. (1994) Cancer Res. 54, 1707-1714 [Abstract]
  27. Herbert, J. M., Augereau, J. M., Gleye, J., and Maffrand, J. P. (1990) Biochem. Biophys. Res. Commun. 172, 992-999
  28. Wenzel-Siefert, K., Schächtele, C., and Siefert, R. (1994) Biochem. Biophys. Res. Commun. 200, 1536-1543 [CrossRef][Medline] [Order article via Infotrieve]
  29. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marmé, D., and Schächtele, C. (1993) J. Biol. Chem. 268, 9194-9197 [Abstract/Free Full Text]
  30. Qatsha, K. A., Rudolph, C., Marmé, D., and Schächtele, C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 4674-4678 [Abstract]
  31. Mathews, C. J., Tabcharani, J. A., Chang, X.-B., Riordan, J. R., and Hanrahan, J. W. (1995) Pediatr. Pulmonol. 20, 424 (abstr.)
  32. Chang, E. B., Wang, N. S., and Rao, M. C. (1985) Am. J. Physiol. 249, C356-C361 [Abstract]
  33. Barthelson, R. A., Jacoby, D. B., and Widdicombe, J. H. (1987) Am. J. Physiol. 253, C802-C808 [Abstract/Free Full Text]
  34. Donowitz, M., Cheng, H. Y., and Sharp, G. W. G. (1986) Am. J. Physiol. 251, G509-G417 [Abstract/Free Full Text]
  35. Welsh, M. J. (1987) Am. J. Physiol. 253, C828-C834 [Abstract/Free Full Text]
  36. Bajnath, R. B., Van Den Berghe, N., De Jonge, H. R., and Groot, J. A. (1993) Pflueg. Arch. Eur. J. Physiol. 425, 90-99
  37. Roach, P. J. (1991) J. Biol. Chem. 266, 14139-14142 [Abstract/Free Full Text]
  38. Hwang, T.-C., Nagel, G., Nairn, A. C., and Gadsby, D. C. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4698-4702 [Abstract]
  39. Gunderson, K. L., and Kopito, R. R. (1994) J. Biol. Chem. 269, 19349-19353 [Abstract/Free Full Text]
  40. Newton, A. C. (1995) J. Biol. Chem. 270, 28495-28498 [Free Full Text]
  41. Hanrahan, J. W., Mathews, C. J., Grygorczyk, R., Tabcharani, J. A., Grzelczak, Z., Chang, X.-B., and Riordan, J. R. (1996) J. Exp. Zool. 275, 283-291 [CrossRef][Medline] [Order article via Infotrieve]
  42. Linsdell, P., and Hanrahan, J. W. (1996) J. Physiol. (Lond.) 496, 687-693 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.